Literature DB >> 27761676

Multicompartment analysis of protein-restricted phenylketonuric mice reveals amino acid imbalances in brain.

Kara R Vogel1, Erland Arning2, Teodoro Bottiglieri2, K Michael Gibson3.   

Abstract

BACKGROUND: The mainstay of therapy for phenylketonuria (PKU) remains dietary protein restriction. Developmental and neurocognitive outcomes for patients, however, remain suboptimal. We tested the hypothesis that mice with PKU receiving protein-restricted diets would reveal disruptions of brain amino acids that shed light on these neurocognitive deficits.
METHOD: Phenylalanine hydroxylase-deficient (PKU) mice and parallel controls (both wild-type and heterozygous) were fed custom diets containing 18, 6, and 4 % protein for 3 weeks, after which tissues (brain, liver, sera) were collected for amino acid analysis profiling.
RESULTS: Phenylalanine (phe) was increased in all tissues (p < 0.0001) of PKU mice and improved with protein restriction. In sera, decreased tyrosine (p < 0.01) was corrected (defined as not significantly different from the level in control mice receiving 18 % chow) with protein restriction, whereas protein restriction significantly increased many other amino acids. A similar trend for increased amino acid levels with protein restriction was also observed in liver. In brain, the effects of protein restriction on large neutral amino acids (LNAAs) were variable, with some deficit correction (threonine, methionine, glutamine) and no correction of tyrosine under any dietary paradigm. Protein restriction (4 % diet) in PKU mice significantly decreased lysine, arginine, taurine, glutamate, asparagine, and serine which had been comparable to control mice under 18 % protein intake.
CONCLUSION: Depletion of taurine, glutamate, and serine in the brain of PKU mice with dietary protein restriction may provide new insight into neurocognitive deficits of PKU.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27761676     DOI: 10.1007/s10545-016-9984-3

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  21 in total

1.  Characterization of 2-(methylamino)alkanoic acid capacity to restrict blood-brain phenylalanine transport in Pah enu2 mice: preliminary findings.

Authors:  Kara R Vogel; Erland Arning; Brandi L Wasek; Teodoro Bottiglieri; K Michael Gibson
Journal:  Mol Genet Metab       Date:  2013-08-15       Impact factor: 4.797

Review 2.  Open questions concerning taurine with emphasis on the brain.

Authors:  Simo S Oja; Pirjo Saransaari
Journal:  Adv Exp Med Biol       Date:  2015       Impact factor: 2.622

3.  The expression and phosphorylation of acid sensing ion channel 1a in the brain of a mouse model of phenylketonuria.

Authors:  Lili Liang; Xuefan Gu; Duan Li; Lihua Lu
Journal:  Int J Neurosci       Date:  2011-07       Impact factor: 2.292

4.  Long-term changes in glutamatergic synaptic transmission in phenylketonuria.

Authors:  A V Glushakov; O Glushakova; M Varshney; L K Bajpai; C Sumners; P J Laipis; J E Embury; S P Baker; D H Otero; D M Dennis; C N Seubert; A E Martynyuk
Journal:  Brain       Date:  2005-01-05       Impact factor: 13.501

Review 5.  Neuroglial Transmission.

Authors:  Vidar Gundersen; Jon Storm-Mathisen; Linda Hildegard Bergersen
Journal:  Physiol Rev       Date:  2015-07       Impact factor: 37.312

6.  [Free amino acids in the saliva of children with phenylketonuria].

Authors:  N Liappis; B Pohl; H P Weber; H el-Karkani
Journal:  Klin Padiatr       Date:  1986 Jan-Feb       Impact factor: 1.349

7.  Physiological Competition of Brain Phenylalanine Accretion: Initial Pharmacokinetic Analyses of Aminoisobutyric and Methylaminoisobutyric Acids in Pahenu2-/- Mice.

Authors:  Kara R Vogel; Garrett R Ainslie; Brian Phillips; Erland Arning; Teodoro Bottiglieri; Danny D Shen; K Michael Gibson
Journal:  Mol Genet Metab Rep       Date:  2015-06-01

8.  Relationship between age and white matter integrity in children with phenylketonuria.

Authors:  Erika Wesonga; Joshua S Shimony; Jerrel Rutlin; Dorothy K Grange; Desiree A White
Journal:  Mol Genet Metab Rep       Date:  2016-04-08

9.  Ten years of specialized adult care for phenylketonuria - a single-centre experience.

Authors:  Ulrike Mütze; Alena Gerlinde Thiele; Christoph Baerwald; Uta Ceglarek; Wieland Kiess; Skadi Beblo
Journal:  Orphanet J Rare Dis       Date:  2016-03-24       Impact factor: 4.123

10.  Executive function in adolescents with PKU and their siblings: Associations with biochemistry.

Authors:  R Sharman; K Sullivan; R Young; J McGill
Journal:  Mol Genet Metab Rep       Date:  2015-08-24
View more
  6 in total

Review 1.  The road ahead for health and lifespan interventions.

Authors:  Marta Gonzalez-Freire; Alberto Diaz-Ruiz; David Hauser; Jorge Martinez-Romero; Luigi Ferrucci; Michel Bernier; Rafael de Cabo
Journal:  Ageing Res Rev       Date:  2020-02-25       Impact factor: 10.895

2.  AMP-activated protein kinase activation in mediating phenylalanine-induced neurotoxicity in experimental models of phenylketonuria.

Authors:  Lihua Lu; Xiaoming Ben; Lingling Xiao; Min Peng; Yongjun Zhang
Journal:  J Inherit Metab Dis       Date:  2017-12-11       Impact factor: 4.982

3.  Metabolomic analyses of vigabatrin (VGB)-treated mice: GABA-transaminase inhibition significantly alters amino acid profiles in murine neural and non-neural tissues.

Authors:  Dana C Walters; Erland Arning; Teodoro Bottiglieri; Erwin E W Jansen; Gajja S Salomons; Madalyn N Brown; Michelle A Schmidt; Garrett R Ainslie; Jean-Baptiste Roullet; K Michael Gibson
Journal:  Neurochem Int       Date:  2019-02-26       Impact factor: 3.921

4.  Large neutral amino acid status in association with P:T ratio and diet in adult and pediatric patients with phenylketonuria.

Authors:  Teresa D Douglas; Anita M Nucci; Ann M Berry; Sarah T Henes; Rani H Singh
Journal:  JIMD Rep       Date:  2019-09-16

5.  Examining the blood amino acid status in pretherapeutic patients with  hyperphenylalaninemia.

Authors:  Lili Liang; Jun Ye; Lianshu Han; Wenjuan Qiu; Huiwen Zhang; Yongguo Yu; Tianwen Zhu; Feng Xu; Xia Zhan; Peizhong Bao; Wenjun Ji; Xuefan Gu
Journal:  J Clin Lab Anal       Date:  2019-11-24       Impact factor: 2.352

6.  Blood phenylalanine reduction reverses gene expression changes observed in a mouse model of phenylketonuria.

Authors:  Rachna Manek; Yao V Zhang; Patricia Berthelette; Mahmud Hossain; Cathleen S Cornell; Joseph Gans; Gulbenk Anarat-Cappillino; Sarah Geller; Robert Jackson; Dan Yu; Kuldeep Singh; Sue Ryan; Dinesh S Bangari; Ethan Y Xu; Sirkka R M Kyostio-Moore
Journal:  Sci Rep       Date:  2021-11-24       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.